Characteristics and performance of the first commercial multileaf collimator for a robotic radiosurgery system

Purpose: The "InCise (TM) multileaf-collimator (MLC)" is the first commercial MLC to be mounted on a robotic SRS/SBRT platform (CyberKnife). The authors assessed characteristics and performance of this novel device in a preclinical five months test period. Methods: Commissioning beam data were acquired with unshielded diodes. EBT3 radiochromic films were employed for measurement of transmission, leaf/bank position accuracy (garden fence) before and after exercising the MLC, for end-to-end testing and further characterization of the beam. The robot workspace with MLC was assessed analytically by transformation to an Euler geometry ("plane," "gantry," and "collimator" angles) and by measuring pointing accuracy at each node. Stability over time was evaluated in picket fence and adapted Winston-Lutz tests (AQA). Results: Beam penumbrae (80%-20%, with 100% = 2xdose at inflection point for field sizes >= 50 x 50 mm(2)) were 2.2-3.7 mm for square fields in reference condition (source-axis-distance 800 mm, depth 15 mm) and depended on field size and off-axis position. Transmission and leakage did not exceed 0.5%. Accessible clinical workspace with MLC covered non-coplanar gantry angles of [-113 degrees; +112 degrees] and collimator angles of [-100 degrees; +107 degrees], with an average robot pointing accuracy of 0.12 +/- 0.09 mm. For vertical beams, garden fence tests exhibited an average leaf positioning error of <= 0.2 mm, which increased by 0.25 and 0.30 mm (banks X1 and X2) with leaves traveling parallel to gravity. After execution of a leaf motion stress routine, garden fence tests showed slightly increased jaggedness and allowed to identify one malfunctioning leaf motor. Total system accuracy with MLC was 0.38 +/- 0.05 mm in nine end-to-end tests. Picket fence and AQA tests displayed stable results over the test period. Conclusions: The InCise (TM) MLC for CyberKnife showed high accuracy and adequate characteristics for SRS/SBRT applications. MLC performance after exercise demands specific quality assurance measures. (C) 2016 American Association of Physicists in Medicine

Intensity modulated radiation therapy planning for patients with a metal hip prosthesis based on class solutions

Purpose: With the aging of the population, an increasing number of patients with metallic hip implants are referred for radiotherapy treatment. Class solutions for intensity modulated radiation therapy (IMRT) treatment planning are generally not applicable for these patients due to the required avoidance of dose delivery through prostheses. In this work a new approach for IMRT planning is presented, allowing the use of a default beam setup. Methods and Materials: For IMRT planning, Monaco (Elekta; CMS Software, Maryland Heights, MO) was used. In addition to the target and organs at risk, so-called prosthesis avoidance volumes (PAVs) were delineated in the beam's eye view projection for beams in which the prosthesis was partially in front of the target. By putting strict constraints on these virtual organs at risk, entrance dose delivery through a prosthesis is avoided while exit dose delivery is allowed. In this way, uncertainties in the dose delivery to the target and organs at risk, as derived by the treatment planning system, are largely minimized. To show the advantages of this IMRT-PAV technique, for 2 prostate cancer patients, 1 with bilateral and the other with unilateral metallic hip prostheses, obtained IMRT plans were compared with conventional IMRT plans using a prosthesis-avoiding beam setup. Results: For both IMRT techniques a similar planning target volume coverage was achieved, but with the IMRT-PAV technique the mean doses to the bladder and the rectum were reduced by up to 25%. While the IMRT-PAV technique required more time for delineation, the time for treatment planning reduced because the default beam setup could be applied. The number of segments needed for dose delivery was comparable for both techniques. Conclusions: With the new IMRT-PAV technique IMRT class solutions can safely be applied for cancer patients with metallic hip prostheses, generally yielding a reduced dose delivery to organs at risk or improved target coverage.</p